VYNE Therapeutics (VYNE) Revenue Growth (3y) (2019 - 2026)
VYNE Therapeutics (VYNE) Revenue Growth (3y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 50.07% |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 7.94% |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 4.47% |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 79.44% |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | VYNE Therapeutics | 1.19 Bn | 1.16 Bn | - | -4.90% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -4.90% |
| Jun 30, 2025 | -7.41% |
| Mar 31, 2025 | 3.96% |
| Dec 31, 2024 | -32.76% |
| Sep 30, 2024 | -3.10% |
| Jun 30, 2024 | -12.44% |
| Mar 31, 2024 | -24.24% |
| Dec 31, 2023 | -73.92% |
| Sep 30, 2023 | -67.33% |
| Jun 30, 2023 | -79.55% |
| Mar 31, 2023 | -61.48% |
| Dec 31, 2022 | -40.11% |
| Mar 31, 2022 | -16.70% |
| Dec 31, 2021 | 26.80% |
| Jun 30, 2021 | -69.25% |
| Mar 31, 2021 | -22.65% |
| Dec 31, 2020 | 15.59% |
| Sep 30, 2020 | 53.21% |
| Jun 30, 2020 | 196.37% |
| Mar 31, 2020 | 57.37% |